1α,25-Dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization-Reference-Cited by-同舟云学术

1α,25-Dihydroxyvitamin D3 and rosiglitazone synergistically enhance osteoblast-mediated mineralization

Published:2013-01 Issue:2 Volume:512 Page:438-443
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Woeckel V.J.,Bruedigam C.,Koedam M.,Chiba H.,van der Eerden B.C.J.,van Leeuwen J.P.T.M.

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference47 articles.

1. Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage;Addison;J. Bone Miner. Res.,2010

2. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors;Akune;J. Clin. Invest.,2004

3. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3;Atkins;Bone,2007

4. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism;Barthel;J. Steroid Biochem. Mol. Biol.,2007

5. Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel;Boskey;Bone Miner.,1993

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene Expression Analyses in Models of Rosiglitazone-Induced Physiological and Pathological Mineralization Identify Novel Targets to Improve Bone and Vascular Health;Cells;2023-10-16

2. Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts;Nutrients;2023-01-17

3. PPARγ Regulates Triclosan Induced Placental Dysfunction;Cells;2021-12-28

4. Effects of Extracellular Osteoanabolic Agents on the Endogenous Response of Osteoblastic Cells;Cells;2021-09-10

5. Vitamin D history part III: the “modern times”—new questions for orthopaedic practice: deficiency, cell therapy, osteomalacia, fractures, supplementation, infections;International Orthopaedics;2019-04-29